Limited‐disease small‐cell lung cancer
- 18 September 2003
- journal article
- review article
- Published by Wiley in Seminars in Surgical Oncology
- Vol. 21 (3) , 156-163
Abstract
Substantial improvements in treatment outcome for limited‐disease small‐cell lung cancer (LD SCLC) have been achieved in the last two decades owing to the introduction of chemotherapy (CHT) consisting of cisplatin and etoposide (PE), and the understanding that thoracic radiation therapy (TRT) is an essential component in improving treatment outcome. In addition, a recent metaanalysis confirmed the importance of prophylactic cranial irradiation (PCI) in general treatment plans for patients who show a complete response to treatment. However, numerous questions remain unanswered regarding this disease. While TRT/PE/PCI is considered to be the standard treatment in the majority of centers worldwide, the emergence of new and effective drugs (e.g., topoisomerase I inhibitors and paclitaxel) for the treatment of LD SCLC will likely affect therapy strategies in the near future. Important issues regarding optimal doses and fractionation regimens, as well as the timing of TRT, remain to be resolved. While most centers currently use b.i.d. fractionation as a result of the Intergroup findings, high‐dose standard TRT may also be beneficial. TRT volumes are also considered an important issue, since they likely relate to the incidence of both local failure and toxicity. Finally, the optimization of PCI (total dose, fractionation regimen, and timing) is already under way. The value of surgery is limited to peripheral tumors and poorly responding cancer, and to confirm histology or improve local control and survival. Semin. Surg. Oncol. 21:156–163, 2003.Keywords
This publication has 49 references indexed in Scilit:
- Pathology of small cell carcinoma of the lungSeminars in Oncology, 2003
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trialEuropean Journal of Cancer, 1997
- Long-term follow-up of a randomised trial of combined chemoradiotherapy induction treatment, with and without maintenance chemotherapy in patients with small cell carcinoma of the lungEuropean Journal of Cancer, 1996
- Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer in Complete RemissionJNCI: Journal of the National Cancer Institute, 1995
- Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 1991
- Staging and prognostic factors in small cell lung cancer: a consensus reportLung Cancer, 1989
- Prophylactic cranial irradiation and small cell lung cancerCancer Treatment Reviews, 1988
- Chemotherapy with or without Radiation Therapy in Limited Small-Cell Carcinoma of the LungNew England Journal of Medicine, 1987
- Thoracic and elective brain irradiation with concomitant or delayed multiagent chemotherapy in the treatment of localized small cell carcinoma of the lung: A randomized prospective study by the southeastern cancer study groupCancer, 1981